April 13, 2015 | The international biomed fund OrbiMed is considering raising a second fund in Israel, according to a “Globes” report. OrbiMed reportedly hopes to raise between $200-250 million, though the group has not yet begun recruiting investors. In Israel, OrbiMed is headed by Senior Managing Director Dr. Nissim Darvish together with Anat Naschitz andĀ Erez Chimovits, among others.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Tech Deters Distracted Drivers In New Italian Pilot
November 28, 2023

German Health Firm Enlists Israeli 3D Printer To Boost CT Imaging
November 28, 2023

Biotech Firm Unveils New Inflammatory Disease, Cancer Therapy
November 27, 2023

Global Money Transfer Firm Brings In Israeli AI Financial Watchdog
November 27, 2023
Facebook comments